CMS Open Payments · Program Year 2024
Boehringer Ingelheim Espana S.A.
Boehringer Ingelheim Espana S.A. reported $382,770.85 in payments to 2 physicians and teaching hospitals across 32 transactions.
- $382.8K
- Total payments
- 32
- Transactions
- 2
- Recipients
- #837
- of 1,925 companies
Boehringer Ingelheim Espana S.A. reported $382,770.85 in payments to 2 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #837 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $191.4K per recipient across 1 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
The verdict
Boehringer Ingelheim Espana S.A. pairs above-median payment volume with a concentrated payment pattern focused on a handful of top recipients.
- #837
- of 1,925 companies
- 0.0%
- of all US industry payments
- 0.6%
- paid to its single top recipient
- 1
- payment categories
How Boehringer Ingelheim Espana S.A. ranks nationally
Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.
Boehringer Ingelheim Espana S.A.'s total vs. every reporting company
CMS Open Payments, Program Year 2024
$382,771 Top 43% higher than 57% of 1,925 reporting companies
Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Open Payments · 2024
What the Data Shows for Boehringer Ingelheim Espana S.A.
In Program Year 2024, Boehringer Ingelheim Espana S.A. reported $382,770.85 in payments to 2 physicians and teaching hospitals across 32 individual transactions, an average of $12.0K per transaction and $191.4K per recipient. That total places Boehringer Ingelheim Espana S.A. at rank #837 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
The 1-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Compensation for Services Other Than Consulting" at $1.6K, accounting for 0.4% of the company's reported total and 2 transactions.
General Payment Breakdown by Type
"Compensation for Services Other Than Consulting" leads Boehringer Ingelheim Espana S.A.'s 1-category general-payment breakdown at $1.6K, 0.4% of the reported total.
How Boehringer Ingelheim Espana S.A. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $1.6K | 2 | 0.4% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $1,575.36 (100.0%) of $1,575.36 in this company's General Payments records across 2 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Boehringer Ingelheim Espana S.A.
The five named recipients with the highest reported General Payments from this company
- 1
Stephen Marder
$969.45 across 1 reported transactions
- 2
Christoph U Correll
$605.91 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Payment Size Analysis
Average transaction size: $12.0K. Average per recipient: $191.4K.
Total Amount
$382,770.85
Avg per Transaction
$12.0K
Avg per Recipient
$191.4K
Payment Transparency Context
What is the Sunshine Act?
The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.
Industry Total (2024)
$13.9B
across 1,925 companies
Boehringer Ingelheim Espana S.A. Share
0.0%
#837 by total payments
Companies with Similar Payment Volumes
Pharmaceutical companies with payment totals similar to Boehringer Ingelheim Espana S.A.
Frequently Asked Questions
How much did Boehringer Ingelheim Espana S.A. pay to physicians and hospitals in 2024? ▾
How many physicians received payments from Boehringer Ingelheim Espana S.A.? ▾
What types of payments did Boehringer Ingelheim Espana S.A. make? ▾
How does Boehringer Ingelheim Espana S.A. rank among pharmaceutical companies? ▾
What is the average payment size from Boehringer Ingelheim Espana S.A.? ▾
Where does the payment data for Boehringer Ingelheim Espana S.A. come from? ▾
Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.